Jean-luc Davignon
Toulouse, 31059, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients.
Journal: International journal of molecular sciences
Published: May 09, 2025
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation.
Journal: Diagnostics (Basel, Switzerland)
Published: April 22, 2025
Productive HIV-1 infection of tissue macrophages by fusion with infected CD4+ T cells.
Journal: The Journal of cell biology
Published: May 20, 2022
Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation.
Journal: iScience
Published: July 28, 2020
Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.
Journal: The Journal of biological chemistry
Published: July 17, 2020
Inhibition of Osteoclastogenesis by the RNA-Binding Protein QKI5: a Novel Approach to Protect from Bone Resorption.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: September 10, 2019
Corrigendum: Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism.
Journal: Frontiers in immunology
Published: August 02, 2019
The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection.
Journal: Nature immunology
Published: July 26, 2019
Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism.
Journal: Frontiers in immunology
Published: February 08, 2019
Osteoclast-Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 23, 2018
Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism.
Journal: Frontiers in immunology
Published: June 25, 2018
Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 22, 2018
Last Updated: 09/26/2026